NIH to Drop “Alternative From Center’s Name; Integrative Better Describes Current Focus

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

YOU MAY BE INTERESTED IN

I have spent over 20 years running a tumor imaging metrics core at an academic cancer center. In that time, I have watched clinical trial enrollment concentrate at a relatively small number of flagship academic institutions. Unfortunately, trials do not propagate well to the community sites where most patients prefer to receive care. The explanations usually offered for why this happens have never fully accounted for what I observed.
Tessa Vellek
Tessa Vellek

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login